Health Care & Life Sciences » Pharmaceuticals | Mezzion Pharma Co. Ltd.

Mezzion Pharma Co. Ltd. | Mutual Funds

Mutual Funds that own Mezzion Pharma Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares III Plc - MSCI Emerging Markets Small Cap
4,002
0.05%
0
0.06%
09/05/2018
iShares MSCI Emerging Markets Small Cap ETF
2,925
0.03%
0
0.08%
09/05/2018
iShares II Plc - MSCI AC Far East (ex-Japan) Small Cap
682
0.01%
0
0.08%
09/05/2018
SSgA SPDR ETFs Europe I Plc - MSCI Em. Mkts. Small Cap UCITS
387
0%
0
0.03%
09/05/2018
252
0%
-435
0.53%
01/31/2017

About Mezzion Pharma Co.

View Profile
Address
3th Floor, C&H Building
Seoul SL 06167
Korea, Republic Of
Employees -
Website http://www.mezzion.co.kr
Updated 09/14/2018
Mezzion Pharma Co., Ltd. engages in the development, production, and licensing of pharmaceutical products. Its products include erectile dysfunction, benign prostatic hyperplasia, and fontan therapeutic drugs. The company was founded by Park Dong-Hyun on September 25, 2002 and is headquartered in Seoul, South Korea.